Showing 21-40 of 644 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Amisulpride for schizophrenia
Cochrane Systematic Reviews, 22-Apr-2002
The treatment of schizophrenia with old, 'typical' antipsychotic drugs such as haloperidol can be problematic, because many people treated with these drugs will suffer from movement disorders. Amisulpride is said to be an "atypical" antipsychotic which in
- Amisulpride versus other atypical antipsychotics for schizophrenia
Cochrane Systematic Reviews, 20-Jan-2010
In many countries of the industrialised world second generation (atypical) antipsychotics have become first line drug treatments for people with schizophrenia. The question as to whether, and if so how much, the effects of the various second generation an
- Amitriptyline for depression
Cochrane Systematic Reviews, 31-Oct-2008
For many years amitriptyline has been considered one of the reference compounds for the pharmacological treatment of depression. However, new tricyclic drugs, heterocyclic compounds and selective serotonin reuptake inhibitors have been introduced on the m
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
Cochrane Systematic Reviews, 9-Aug-2018
Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder characterised by inattention, hyperactivity, and impulsivity. ADHD can persist into adulthood and can affects individuals' social and occupational functioning, as well as their
- Amphetamines for schizophrenia
Cochrane Systematic Reviews, 19-Jul-2004
It is estimated that between 10% and 65% of people with schizophrenia use illicit drugs such as amphetamines. This group have an increased rate of hospitalisation, homelessness, unemployment and suicide compared with those with schizophrenia who do not ab
- Anabolic‐androgenic steroids for alcoholic liver disease
Cochrane Systematic Reviews, 18-Oct-2006
Alcohol is one of the most common causes of liver disease in the Western World. Randomised clinical trials have examined the effects of anabolic-androgenic steroids for alcoholic liver disease.
- Anticholinergic medication for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 17-Jan-2018
Antipsychotic (neuroleptic) medication is used extensively to treat people with serious mental illnesses. However, it is associated with a wide range of adverse effects, including movement disorders. Because of this, many people treated with antipsychotic
- Anticonvulsants for alcohol withdrawal
Cochrane Systematic Reviews, 17-Mar-2010
Alcohol abuse and dependence represents a most serious health problem worldwide with major social, interpersonal and legal interpolations. Besides benzodiazepines, anticonvulsants are often used for the treatment of alcohol withdrawal symptoms. Anticonvul
- Anticonvulsants for cocaine dependence
Cochrane Systematic Reviews, 17-Apr-2015
Cocaine dependence is a major public health problem that is characterised by recidivism and a host of medical and psychosocial complications. Although effective pharmacotherapy is available for alcohol and heroin dependence, none is currently available fo
- Antidepressant drugs for narcolepsy
Cochrane Systematic Reviews, 11-May-2010
This is an updated version of the original Cochrane review published in Issue 1, 2008.
- Antidepressant treatment for postnatal depression
Cochrane Systematic Reviews, 11-Sep-2014
Postnatal depression is a common disorder that can have adverse short- and long-term effects on maternal morbidity, the new infant and the family as a whole. Treatment is often largely by social support and psychological interventions. It is not known whe
- Antidepressants for agitation and psychosis in dementia
Cochrane Systematic Reviews, 18-Jan-2011
Agitation and psychosis are common among older adults with dementia and are challenging to manage. At the present time, little is known about the efficacy and safety of antidepressant medications when used to treat these symptoms.
- Antidepressants for anorexia nervosa
Cochrane Systematic Reviews, 31-Oct-2008
Anorexia Nervosa (AN) is an illness characterised by extreme concern about body weight and shape, severe self-imposed weight loss, and endocrine dysfunction. In spite of its high mortality, morbidity and chronicity, there are few intervention studies on t
- Antidepressants for depressed elderly
Cochrane Systematic Reviews, 25-Jan-2006
Depression is a relatively common experience in older adults. The syndrome is associated with considerable distress, morbidity and service commitment. Approximately two thirds of patients presenting with severe forms will respond to antidepressant treatme
- Antidepressants for depression in medical illness
Cochrane Systematic Reviews, 30-Oct-2008
Depression in the physically unwell is common and an important cause of morbidity. There are problems with diagnosing depression in the physically ill which may lead to under-recognition and under-treatment. In clinical practice antidepressants are availa
- Antidepressants for generalised anxiety disorder (GAD)
Cochrane Systematic Reviews, 10-Mar-2016
Pharmacological treatments have been successfully used to treat Generalized Anxiety Disorder (GAD). Benzodiazepine and non benzodiazepine anxiolytics used to be the mainstay for the pharmacological treatment of GAD. However, data emerging over the last tw
- Antidepressants for neuropathic pain
Cochrane Systematic Reviews, 27-Jan-2014
This is an updated version of the original Cochrane review published in Issue 3, 2005 of The Cochrane Library
. For many years antidepressant drugs have been used to manage neuropathic pain, and are often the first choice treatment. It is not clear, howev
- Antidepressants for non‐specific low back pain
Cochrane Systematic Reviews, 23-Jan-2008
Antidepressants are commonly used in the management of low-back pain. However, their use is controversial.
- Antidepressants for patients with tinnitus
Cochrane Systematic Reviews, 12-Sep-2012
This is an update of a Cochrane review first published in The Cochrane Library in Issue 4, 2006 and previously updated in 2009.
- Antidepressants for people with both schizophrenia and depression
Cochrane Systematic Reviews, 22-Apr-2002
Depressive symptoms, often of substantial severity, are found in 50% of newly diagnosed suffers of schizophrenia and 33% of people with chronic schizophrenia who have relapsed. Depression is associated with dysphoria, disability, reduction of motivation t
